NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $906,000 | -49.7% | 125,331 | -35.8% | 0.02% | -50.0% |
| Q2 2021 | $1,801,000 | -27.0% | 195,076 | -2.7% | 0.03% | -34.6% |
| Q1 2021 | $2,468,000 | -28.9% | 200,518 | -18.6% | 0.05% | -33.3% |
| Q4 2020 | $3,473,000 | -2.4% | 246,299 | -16.9% | 0.08% | -35.5% |
| Q3 2020 | $3,558,000 | -22.0% | 296,511 | +7.9% | 0.12% | -26.7% |
| Q2 2020 | $4,562,000 | – | 274,808 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |